These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6871107)

  • 1. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza').
    Barbui T; Finazzi G; Rodeghiero F; Dini E
    Br J Haematol; 1983 Aug; 54(4):561-5. PubMed ID: 6871107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').
    Finazzi G; Barbui T; Tran TH; Duckert F
    Ric Clin Lab; 1984; 14(3):515-9. PubMed ID: 6522961
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
    Sakuragawa N; Takahashi K; Kondo S; Koide T
    Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
    Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
    Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
    Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
    Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern.
    Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B
    Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Swedish family with abnormal antithrombin III.
    Tengborn L; Frohm B; Nilsson LE; Nilsson IM
    Scand J Haematol; 1985 May; 34(5):412-6. PubMed ID: 4012220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hereditary heparin co-factor II deficiency with thrombosis.
    Tran TH; Marbet GA; Duckert F
    Lancet; 1985 Aug; 2(8452):413-4. PubMed ID: 2863444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antithrombin III heterogeneity.
    Williams L; Murano G
    Blood; 1981 Feb; 57(2):229-32. PubMed ID: 6160891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An abnormal plasma antithrombin with no apparent affinity for heparin.
    Chasse JF; Esnard F; Guitton JD; Mouray H; Perigois F; Fauconneau G; Gauthier F
    Thromb Res; 1984 May; 34(4):297-302. PubMed ID: 6204398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis.
    Johansson L; Hedner U; Nilsson IM
    Acta Med Scand; 1978; 204(6):491-5. PubMed ID: 735880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
    Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.